Popular Airborne Cold Remedy Must Repay Customers

The popular cold remedy Airborne must now repay some $23 million to customers because its claims are false. The company was first investigated by Good Morning America. The investigation led to a class action lawsuit.

Airborne must repay its customers because the product doesn't work. The company claimed that it could cure the common cold. Some advertising said the product could cure it in under an hour. However, the company's CEO is now backpedaling, saying she doesn't know if it is a cure. The product's clinical trials were conducted by two people at a small home in the suburbs. One of the testers claimed to have advanced degrees. This, however, turns out to be false. The Federal Trade Commission is investigating whether or not to punish the company further. A spokesperson said Airborne is just a fancy Vitamin C delivery system. The class action lawsuit was settled in favor of consumers because Airborne is a dietary supplement, and as such, it must back up any claims it makes. The company aggressively advertised the product as a cure for the cold, making it liable for those claims. If you purchased Airborne, you can get refunds for all of the product you ever purchased with receipts. Without a receipt, you can get money back for up to six boxes, which comes to about $63.